Central nervous system relapse is uncommon after chimeric antigen receptor T-cell therapy for relapsed/refractory large B-cell lymphoma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Gloria Iacoboni, Emmanuel Bachy, Victor Navarro, Tom Van Meerten, Paula Fernández-Caldas, Carolyn Maharaj, Ana Africa Martin Lopez, Tobias Tix, Ana Benzaquen, Sandra Perez, Javier Delgado Serrano, Sergi Camarillas, Cristina García Herce, Mariana Bastos-Oreiro, Pierre Sesques, Imran Malik, Maria Teresa Villalobos, Ana Jiménez Ubieto, Lucia Medina, Sonia González De Villambrosia, Claire Roddie, Hilde Van Der Galien, Marieke Tienstra, Maryam Idlhaj, Pablo Silva, Lucia Lopez Corral, Paola Villafuerte Gutiérrez, Ana Saus Carreres, Santiago Browne, Blanca Sanchez, Daniel García Belmonte, Fátima de la Cruz, Marion Subklewe, Rafael Hernani, Mi Kwon, Maeve O'Reilly, Kai Rejeski, Alejandro Martin Garcia-Sancho, Leyre Bento De Miguel, Pere Barba, Pau Abrisqueta
Institutions: Vall d'Hebron Hospital Universitari, Hospices Civils de Lyon, Vall d'Hebron Institute of Oncology, University Medical Center Groningen, University of Groningen, Hospital General Universitario Gregorio Marañón, University College London, Complejo Hospitalario de Salamanca, LMU Klinikum, Ludwig-Maximilians-Universität München, Hospital Clínico Universitario de Valencia, Hospital Universitario Son Espases, Hospital Universitario Virgen del Rocío, University Hospital Mútua de Terrassa, Hospital Universitario 12 De Octubre, Marqués de Valdecilla University Hospital, Universidad de Navarra, Hospital Del Mar, Hospital Universitario Sanitas La Zarzuela
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417014897
Cites:
Cited by:
Related to: